News

Cannara gets coveted shelf space for vapes in Quebec

Published on August 8, 2025 by Pat Bulmer

Photo: Contributed

Another Quebec company has secured some of the limited shelf space that will be available when vaping products become legal in the province.

Montreal-based Cannara Biotech says it has received preliminary acceptance to sell five vape cartridge products in government cannabis stores starting in November.

The products will also be sold online.

“We are incredibly proud to announce our preliminary approval of five live resin and live rosin vape cartridges to be distributed across Quebec’s 107 retail stores,” said Zohar Krivorot, company president and CEO. “We are excited to enter Quebec’s vape cartridge category launch with our most popular strains in live resin format.”

Rosin cartridges are a new category for the company.

“These live rosin vapes represent the highest-quality flower input— grown, flash frozen and extracted entirely in-house at our Valleyfield and Farnham facilities in Quebec,” the company said in a news release.

“This launch of live rosin vapes represents the culmination of months of research and development around genetic selection, process refinement and hardware,” said Nicholas Sosiak, company CFO.

Earlier, Montreal-based Mercanto Holdings announced it had received preliminary approval to sell three vape cartridge products in Quebec.

Following the vape announcement, Cannara reported it had a record-breaking quarter financially and was growing more pot than ever.

“The optimization of our cultivation procedures … has resulted in a 26% yield improvement across our facilities, allowing Cannara to achieve our fiscal 2026 cultivation target a full year ahead of schedule,” said Krivorot. Annual capacity has risen from 39,500 kilograms to 50,000 kg, the financial report said.

“Fiscal Q3 2025 represents another record-breaking quarter for Cannara, producing records for revenue, gross profit, gross margin, adjusted EBITDA (earnings before interest, taxes, depreciation and amortization), adjusted EBITDA margin, operating cash flow and free cash flow,” said Krivorot in the financial statement.

Added CFO Sosiak: “We delivered our 17th consecutive quarter of positive adjusted EBITDA, generating a record-high of $7.6 million … Operating cash flow surged to a record high of $13.9 million.”

In a presentation for shareholders, Cannara said it is the seventh largest licenced producer in sales across Canada and No. 2 in Quebec. Tribal, Nugz and Orchid CBD are Cannara’s top brands.

Unlike some cannabis company that see medical exports as their future, Cannara is focused on growth in Canada, said Sosiak in the presentation.